FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
  1. Home
  2. KANORICHEM Forum

KANORICHEM

193 +5.9 (3.15%)
Updated 12:23 28/09 IST
0% Bullish
0% Bearish
0 Users have submitted 0 trade ideas of Rs. 0 for KANORICHEM
Disclaimer

Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See KANORICHEM Share Price Targets >>

KANORICHEM Share Price Discussion


Type
Buy
Instrument
KANORICHEM
Entry Price
₹205
Price@Trade
₹202.85
Target Price
₹235
Stop Price
₹189
Valid Till
Sep 16, 2022 3:20 AM
Margin
₹2,050 approx for 10 Qty
Status
Waiting for entry
Like
Reply
swap_vert
Trade
N
Reputation: 17,738 • Aug 30 12:56 PM
Exporters boxed in by container crunch as rates rise to $7,000-10,000 in fortnight
A severe container shortage – triggered by massive congestions at Chinese ports that are either closed or operating at much lower capacity due to Covid-19 restrictions, along with a huge demand for containers in the US and Europe – has been pushing container rates, which shot up to record levels in the past 10-15 days, industry executives told ET.
The Economic Times
Like
Reply
5
Reputation: 0 • Aug 27 7:22 AM

Type
Buy
Instrument
KANORICHEM
Entry Price
₹140
Price@Trade
₹142.9
Target Price
₹145
Stop Price
₹120
Valid Till
Aug 30, 2021 3:20 AM
Margin
₹3,500 approx for 25 Qty
Status
Exited before entry
Like
Reply (1)
swap_vert
Trade
See all replies
567716 @567716
Aug 30 6:41 AM

Update
Exited before entry
Price @ Update
₹156.35
N
Reputation: 17,738 • Aug 5 6:01 AM
Santosh Kanoria family acquires Jungpana, Goomtee tea estates
Anshuman Kanoria, a member of the Santosh Kanoria family, said "we have bought the two premium tea gardens of Darjeeling, Jungpana and Goomtee. Jungpana is the most premium tea of Darjeeling and fetches a very high average price realisation".
The Economic Times
Like
Reply
Like
Reply

Type
Buy
Instrument
KANORICHEM
Entry Price
₹162.5
Price@Trade
₹162.5
Target Price
₹222
Stop Price
₹130
Valid Till
Jul 6, 2022 3:20 AM
Margin
₹10,562.5 approx for 65 Qty
Status
Exited
Exit Price
₹166.2
Net P&L
+₹240.5 (+2.28%)

Like
Reply (1)
swap_vert
Trade
See all replies
Ketul Vyas @KetulVyas
Jul 19 3:01 AM

Update
Exited
Exit Price
₹166.2
Net P&L
+₹240.5 (+2.28%)

KANORICHEM - chart - 2728727
#KANORICHEM MEDIUM TERM BUY MODE TGT 163/228 SL 110(WEEKLY CLBS)
Like
Reply
N
Reputation: 17,738 • Aug 11, 2020 5:08 AM
Kanoria Chem Standalone June 2020 Net Sales at Rs 35.59 crore, down 65.51% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 17,738 • Aug 11, 2020 4:58 AM
Kanoria Chem Consolidated June 2020 Net Sales at Rs 133.42 crore, down 47.95% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 17,738 • Jun 18, 2020 3:48 AM
Kanoria Chem Consolidated March 2020 Net Sales at Rs 265.09 crore, down 1.61% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 17,738 • Jun 18, 2020 3:48 AM
Kanoria Chem Standalone March 2020 Net Sales at Rs 92.32 crore, down 11.95% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 17,738 • Jun 17, 2020 2:53 AM
Trade Setup for Thursday: Top 15 things to know before Opening Bell
Key support level for the Nifty is placed at 9,808.77, followed by 9,736.38. If the index moves up, the key resistance levels to watch out for are 9,978.57 and 10,075.98.
Moneycontrol
Like
Reply
N
Reputation: 17,738 • Apr 2, 2020 1:43 AM
Trade Setup for Friday: Top 15 things to know before Opening Bell
Key support level for Nifty is placed at 8,105.4, followed by 7,957. If the index starts moving up, key resistance levels to watch out for are 8,495.15 and 8,736.5.
Moneycontrol
Like
Reply
N
Reputation: 17,738 • May 28, 2019 5:18 AM
Like
Reply

KANORICHEM Ratings

Long term KANORICHEM rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live KANORICHEM message board: Is KANORICHEM buy or sell? Should I buy KANORICHEM shares? Why are KANORICHEM shares falling? Should I invest in KANORICHEM stock?

Join FrontPage
Hero Img
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • KANORICHEM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization287.11
    Enterprise Value350.89
    Price to Earnings51.27
    Price to Book Value0.47
    Return on Capital Employed0.02
    Return on Equity0.01
    Face Value5
    Dividend Yield0.02
  • KANORICHEM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 27194.65194.65185.85187.1
    Sep 24200205194.25194.65
    Sep 23213.5217.7202.65204.45
    Sep 22214221.55203.45213.3
    Sep 21207.95211.25197.25211
  • KANORICHEM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹181.8
    30 Day Moving Average₹170.03
    50 Day Moving Average₹172.57
    100 Day Moving Average₹156.12
    200 Day Moving Average₹101.69
  • KANORICHEM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue338.74295.660.15
    Operating Profit13.1810.130.3
    Profit Before Tax8.249.1-0.09
    Net Income5.618.72-0.7
  • KANORICHEM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds609.69614.37-0.01
    Total Liabilities237.85229.960.03
    Total Assets847.54844.330
  • KANORICHEM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity28.627.432.85
    Cash from Investing Activity4.714.040.17
    Cash from Financing Activity-31.78-15.651.03
    Net Cash Flow1.54-4.18-1.37
  • KANORICHEM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.010.02
    Return on Equity0.010.03
    Return on Capital Employed0.020.02
  • KANORICHEM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.09
    3 Year CAGR Growth in Operating Profit0.2
    3 Year CAGR Growth in EBIDTA-0.17
    3 Year CAGR Growth in Net Income-0.63
    3 Yr CAGR Growth - Diluted EPS-0.63
  • KANORICHEM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.4
    5 Year CAGR Growth in Operating Profit5.31
    5 Year CAGR Growth in EBIDTA0.32
    5 Year CAGR Growth in Net Income0.18
    3 Yr CAGR Growth - Diluted EPS0.17
  • KANORICHEM - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 30 12:56 PM
    Exporters boxed in by container crunch as rates rise to $7,000-10,000 in fortnight
    The Economic Times
    NewsBot
    Aug 5 6:01 AM
    Santosh Kanoria family acquires Jungpana, Goomtee tea estates
    The Economic Times
    NewsBot
    Aug 11, 2020 5:08 AM
    Kanoria Chem Standalone June 2020 Net Sales at Rs 35.59 crore, down 65.51% Y-o-Y
    Moneycontrol
    NewsBot
    Aug 11, 2020 4:58 AM
    Kanoria Chem Consolidated June 2020 Net Sales at Rs 133.42 crore, down 47.95% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 18, 2020 3:48 AM
    Kanoria Chem Consolidated March 2020 Net Sales at Rs 265.09 crore, down 1.61% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 18, 2020 3:48 AM
    Kanoria Chem Standalone March 2020 Net Sales at Rs 92.32 crore, down 11.95% Y-o-Y
    Moneycontrol
    NewsBot
    Apr 2, 2020 1:43 AM
    Trade Setup for Friday: Top 15 things to know before Opening Bell
    Moneycontrol
    NewsBot
    May 28, 2019 5:18 AM
    NewsBot
    Feb 13, 2019 12:07 PM
    NewsBot
    Dec 11, 2018 1:47 AM
  • KANORICHEM - Related Communities

    keyboard_arrow_down
    UPL Ltd. NSE: UPL | BSE: 512070 | ISI...
    Tata Chemicals Ltd. NSE: TATACHEM | B...
    Pidilite Industries Ltd. NSE: PIDILIT...
    Deepak Nitrite Ltd. NSE: DEEPAKNTR | ...
    Aarti Industries Ltd. NSE: AARTIIND |...
    Godrej Industries Ltd. NSE: GODREJIND...
    Rallis India Ltd. NSE: RALLIS | BSE: ...
    Navin Fluorine International Ltd. NSE...
    Himadri Speciality Chemical Ltd. NSE:...
    PI Industries Ltd. NSE: PIIND | BSE: ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.